Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 324

1.

Emerging drugs for the treatment of kidney disease-induced anemia.

Malyszko J, Malyszko JS.

Expert Opin Emerg Drugs. 2016 Sep;21(3):315-30. doi: 10.1080/14728214.2016.1220537.

PMID:
27537859
2.

Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study.

Li Y, Shi H, Wang WM, Peng A, Jiang GR, Zhang JY, Ni ZH, He LQ, Niu JY, Wang NS, Mei CL, Xu XD, Guo ZY, Yuan WJ, Yan HD, Deng YY, Yu C, Cen J, Zhang Y, Chen N.

Medicine (Baltimore). 2016 Jun;95(24):e3872. doi: 10.1097/MD.0000000000003872.

4.

Genetic Atypical Hemolytic-Uremic Syndrome.

Noris M, Bresin E, Mele C, Remuzzi G.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016.
2007 Nov 16 [updated 2016 Jun 9].

5.

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.

Cody JD, Hodson EM.

Cochrane Database Syst Rev. 2016 Jan 20;(1):CD003266. doi: 10.1002/14651858.CD003266.pub3. Review.

PMID:
26790135
6.

Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT.

Clin Nephrol. 2016 Feb;85(2):101-11. doi: 10.5414/CN108626.

PMID:
26636331
7.

New Options for Iron Supplementation in Maintenance Hemodialysis Patients.

Vaziri ND, Kalantar-Zadeh K, Wish JB.

Am J Kidney Dis. 2016 Mar;67(3):367-75. doi: 10.1053/j.ajkd.2015.09.031. Review.

PMID:
26616335
8.

Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction.

Hawwa N, Shrestha K, Hammadah M, Yeo PS, Fatica R, Tang WH.

J Am Coll Cardiol. 2015 Oct 20;66(16):1779-87. doi: 10.1016/j.jacc.2015.08.023.

9.

Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan.

Banaga AS, Mohammed EB, Siddig RM, Salama DE, Elbashir SB, Khojali MO, Babiker RA, Elmusharaf K, Homeida MM.

BMC Res Notes. 2015 Sep 29;8:502. doi: 10.1186/s13104-015-1509-x.

10.

Cardiovascular risk factors among patients with chronic kidney disease attending a tertiary hospital in Uganda.

Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, Mondo CK.

Cardiovasc J Afr. 2015 Jul-Aug;26(4):177-80. doi: 10.5830/CVJA-2015-045.

11.

Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry.

Krischock LA, van Stralen KJ, Verrina E, Tizard EJ, Bonthuis M, Reusz G, Hussain FK, Jankauskiene A, Novljan G, Spasojević-Dimitrijeva B, Podracka L, Zaller V, Jager KJ, Schaefer F; ESPN/ERA-EDTA Registry..

Pediatr Nephrol. 2016 Feb;31(2):325-33. doi: 10.1007/s00467-015-3201-8.

PMID:
26385862
12.

How the Target Hemoglobin of Renal Anemia Should Be.

Mimura I, Tanaka T, Nangaku M.

Nephron. 2015;131(3):202-9. doi: 10.1159/000440849. Review.

13.

A cross-sectional study of dialysis practice-patterns in patients with chronic kidney disease on maintenance hemodialysis.

Kulkarni MJ, Jamale T, Hase NK, Jagdish PK, Keskar V, Patil H, Shete A, Patil C.

Saudi J Kidney Dis Transpl. 2015 Sep;26(5):1050-6. doi: 10.4103/1319-2442.164607.

14.

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovich P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA.

Am Heart J. 2015 Aug;170(2):322-9. doi: 10.1016/j.ahj.2015.05.008.

PMID:
26299230
15.

Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.

Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M.

Nutrients. 2015 May 15;7(5):3783-95. doi: 10.3390/nu7053783.

16.

Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.

Monda KL, Joseph PN, Neumann PJ, Bradbury BD, Rubin RJ.

BMC Nephrol. 2015 May 1;16:67. doi: 10.1186/s12882-015-0059-8.

17.

Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study).

Gesualdo L, Combe C, Covic A, Dellanna F, Goldsmith D, London G, Mann JF, Zaoui P, Turner M, Muenzberg M, MacDonald K, Abraham I.

Int Urol Nephrol. 2015 May;47(5):837-45. doi: 10.1007/s11255-015-0970-8.

18.

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J, Heuschmann PU, Wanner C, Schramm L.

PLoS One. 2015 Apr 20;10(4):e0123072. doi: 10.1371/journal.pone.0123072.

19.

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP; Collaborative Study Group..

J Am Soc Nephrol. 2015 Oct;26(10):2578-87. doi: 10.1681/ASN.2014080842.

20.

Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case-control study.

Kim WH, Park MH, Kim HJ, Lim HY, Shim HS, Sohn JT, Kim CS, Lee SM.

Medicine (Baltimore). 2015 Jan;94(2):e273. doi: 10.1097/MD.0000000000000273.

Items per page

Supplemental Content

Loading ...
Support Center